Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Q&A: Paradigm to answer FDA questions to achieve Investigational New Drug status
    • News

    Q&A: Paradigm to answer FDA questions to achieve Investigational New Drug status

    The commercialisation of osteoarthritis treatment ZILOSUL® has hit a hiccup in the United States with the US Food and Drug Administration (FDA) raising fresh questions to late-stage drug development company, Paradigm Biopharmaceuticals (ASX: PAR). The FDA response related to Paradigm’s application for Investigational New Drug status to be granted for their focus compound, Pentosan Polysulfate

    Read More
    Public
  • Zip expands to Europe and Middle East with further strategic acquisitions
    • News

    Zip expands to Europe and Middle East with further strategic acquisitions

    Zip Co’s (ASX: Z1P) global expansion plans are being realised with the Company today announcing the next steps for their push into overseas markets through the outright acquisitions of European BNPL provider Twisto Payments, and UAE-based BNPL leader Spotii Holdings. The move aligns with Zip’s strategic acquisitions plan. Both companies have been integrated into Zip’s

    Read More
    Public
  • Plenty of fish in the sea: Ridley to sell Tasmanian aquaculture facility
    • News

    Plenty of fish in the sea: Ridley to sell Tasmanian aquaculture facility

    Australia’s largest commercial provider of animal nutrition solutions, Ridley Corporation (ASX: RIC) has today announced the sale of their Tasmania extrusion and feed production facility. The sale of the facility to Skretting Australia will put $54.85 million into Ridley’s pocket and is expected to be finalised in the first half of FY22. The Company cites

    Read More
    Public
  • Chinese demand for dairy thriving as Keytone Dairy triples sales
    • News

    Chinese demand for dairy thriving as Keytone Dairy triples sales

    Despite a decline in sales among larger Australian dairy product manufacturers, the smaller guys are still kicking strong as evidenced by Keytone Dairy (ASX: KTD) tripling its exports to China since the start of 2021. Orders have been particularly strong from Walmart China and Sam’s Club China with bulk buying of particular attraction to Chinese

    Read More
    Public
  • Airtasker comes back to market for more capital to fund US expansion
    • News

    Airtasker comes back to market for more capital to fund US expansion

    Just two months after raising $15 million via their IPO, tech company Airtasker (ASX: ART) has returned to the market seeking to raise another $20 million to fund plans to expand into the United States. The expansion will be facilitated by Airtasker’s acquisition of services marketplace Zaarly and its 597,000 registered users and 900+ service

    Read More
    Public
  • My Food Bag revenue increases as hungry Kiwis seek diet variety outside of ‘fush and chups’
    • News

    My Food Bag revenue increases as hungry Kiwis seek diet variety outside of ‘fush and chups’

    Contrary to popular belief, the Kiwis do not only eat ‘fush and chups’. Just like us Aussies, our neighbours do in fact eat a wide and varied diet not dissimilar to ours. My Food Bag (ASX: MFB) is one company delivering fresh ingredients across New Zealand in the form of meal kits. The Company has

    Read More
    Public
  • «
  • ‹
  • 500
  • 501
  • 502
  • 503
  • 504
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.